Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Olaf Heidenreich

Senior group leader

Princess Máxima Center for Pediatric Oncology

Netherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (11)

John Lunec

Gillespie Prof of Molecular Oncology

Newcastle University

UNITED KINGDOM

View details

Sander Kooijmans

Assistant professor

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Peter J.M. Valk

Erasmus MC

NETHERLANDS

View details

Jan Krönke

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Hasan Uludag

University of Alberta

CANADA

View details

Christian Steinebach

Professor of Pharmaceutical/Medicinal Chemistry

University of Greifswald

GERMANY

View details

Anthony Moorman

Professor of Genetic Epidemiology

Newcastle University

UNITED KINGDOM

View details

Simon Bomken

Clinical Senior Lecturer/Hon. Consultant

Newcastle University

UNITED KINGDOM

View details

Joost Martens

Radboud University

NETHERLANDS

View details

Spencer Gibson

Professor

University of Alberta

CANADA

View details

Nidhi Jyotsana

Staff Scientist

Salk Institute for Biological Studies

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olaf Heidenreich

Research Interests

Make your next move.

Explore related searches

Articles (12)

PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia

Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery

HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia

Double trouble for a blurry foe: precision strike on BCL11B

Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment

Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL.

NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities

Targeting the innate immune system in pediatric and adult AML

Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia

Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles

Collaborators (11)

John Lunec

Sander Kooijmans

Peter J.M. Valk

Jan Krönke

Hasan Uludag

Christian Steinebach

Anthony Moorman

Simon Bomken

Joost Martens

Spencer Gibson

Nidhi Jyotsana

Make your next move.